𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination chemotherapy of advanced lung cancer. A randomized trial

✍ Scribed by Heine H. Hansen; Oleg S. Selawry; Richard Simon; David T. Carr; C. E. van Wyk; R. D. Tucker; Rossall Sealy

Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
503 KB
Volume
38
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination of chemotherapy and recombin
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer: Multicentric randomized FONICAP trial report
✍ Andrea Ardizzoni; Franco Salvati; Riccardo Rosso; Paolo Bruzzi; Alessandra Rubag πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 647 KB

Background. Preclinical data suggested that alphainterferon (IFN) may potentiate chemotherapy cytotoxicity. Methods. A prospective multicentric randomized trial was initiated to assess the clinical benefit of adding This work was conducted by the Italian Lung Cancer Task Force (FONICAP), which carr

Combination chemotherapy in advanced lun
Combination chemotherapy in advanced lung cancer with increased survival
✍ Dr. Marc J. Straus πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 844 KB

Twenty-eight patients with lung cancer, 26 with extensive disease, were treated with the drugs Cytoxan (Cyt) and methotrexate (MTX). The schedule was based on cellular kinetics concepts. Initial therapy was with Cyt 1.1 g/m2 (intravenously) followed by MTX 20 mg/m2 orally, twice weekly, started 9 da